Affinity Asset Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
|
|||||
|
2025
Q1 | $22.2M | Buy |
|
|||||
|
2024
Q4 | $18.4M | Buy |
|
|||||
|
2024
Q3 | $15.4M | Sell |
|
|||||
|
2024
Q2 | $10.3M | Buy |
|
|||||
|
2024
Q1 | $9.39M | Buy |
|
|||||
|
2023
Q4 | $6.33M | Sell |
|
|||||
|
2023
Q3 | $6.59M | Buy |
|
|||||
|
2023
Q2 | $5.58M | Buy |
|
|||||
|
2023
Q1 | $2.63M | Buy |
|
|||||
|
2022
Q4 | $1.43M | Buy |
|
|||||
|
2022
Q3 | $975K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $586K | Sell |
|
|||||
|
2021
Q4 | $4.72M | Buy |
|
|||||
|
2021
Q3 | $3.39M | Buy |
|
|||||
|
2021
Q2 | $1.49M | Buy |
|